Genio utilizes an implanted electrode around the hypoglossal nerve, stimulating the tongue and keeping the airway open. The unique design utilizes bilateral stimulation and offers patients a leadless, full-body 1.5T and 3T MRI-compatible, non-implanted battery solution powered and controlled by a wearable component. This fully upgradeable wearable component provides access to the technology without requiring additional surgeries for technology updates or battery replacements.

Mont-Saint-Guibert, Belgium-based Nyxoah received approval for a subset of patients with moderate to severe obstructive sleep apnea (OSA). These patients have an Apnea-Hypopnea Index (AHI) of greater than or equal to 15 and less than or equal to 65.